Center for Substance Abuse Treatment; Notice of Meeting, 15527 [2017-06168]

Download as PDF Federal Register / Vol. 82, No. 59 / Wednesday, March 29, 2017 / Notices Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: May 4, 2017. Open: 8:30 a.m. to 2:30 p.m. Agenda: Report from the Institute Director and other staff. Place: National Institutes of Health, Building 31, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Closed: 3:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, Md 20892, 301–435–0809, anna.ramseyewing@ nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: March 23, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–06148 Filed 3–28–17; 8:45 am] BILLING CODE 4140–01–P Name of Committee: National Institute of Neurological Disorder and Stroke; Special Emphasis Panel, Clinical Trials in Stroke. Date: April 18, 2017. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Shanta Rajaram, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892–9529, (301) 435–6033, rajarams@mail.nih.gov. Name of Committee: National Institute of Neurological Disorder and Stroke; Special Emphasis Panel, Loan Repayment Program 2017. Date: April 28, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Ernest Lyons, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892–9529, (301) 496–4056, lyonse@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: March 23, 2017. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–06149 Filed 3–28–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings mstockstill on DSK3G9T082PROD with NOTICES National Institutes of Health Substance Abuse and Mental Health Services Administration Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 16:54 Mar 28, 2017 Jkt 241001 Center for Substance Abuse Treatment; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Center for Substance Abuse Treatment (CSAT) National Advisory Council will meet on April 12, 2017, 3:00 p.m.–4:00 p.m. (EDT) in a closed teleconference meeting. The meeting will include discussions and evaluations of grant applications reviewed by SAMHSA’s Initial Review Groups, and involve an examination of confidential financial and business information as well as personal PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 15527 information concerning the applicants. Therefore, the meeting will be closed to the public as determined by the SAMHSA Acting Deputy Assistant Secretary for Mental Health and Substance Use in accordance with 5 U.S.C. 552b(c)(4) and (6) and 5 U.S.C. App. 2, 10(d). Meeting information and a roster of Council members may be obtained by accessing the SAMHSA Committee Web site at https://www.samhsa.gov/about-us/ advisory-councils/csat-nationaladvisory-council or by contacting the CSAT National Advisory Council Designated Federal Officer, Tracy Goss (see contact information below). Council Name: SAMHSA’s Center for Substance Abuse Treatment National Advisory Council. Date/Time/Type: April 12, 2017, 3:00 p.m.–4:00 p.m. EDT, CLOSED. Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Tracy Goss, Designated Federal Officer, CSAT National Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), Telephone: (240) 276–0759, Fax: (240) 276–2252, Email: tracy.goss@ samhsa.hhs.gov. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2017–06168 Filed 3–28–17; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 82, Number 59 (Wednesday, March 29, 2017)]
[Notices]
[Page 15527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06168]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Treatment; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA's) 
Center for Substance Abuse Treatment (CSAT) National Advisory Council 
will meet on April 12, 2017, 3:00 p.m.-4:00 p.m. (EDT) in a closed 
teleconference meeting.
    The meeting will include discussions and evaluations of grant 
applications reviewed by SAMHSA's Initial Review Groups, and involve an 
examination of confidential financial and business information as well 
as personal information concerning the applicants. Therefore, the 
meeting will be closed to the public as determined by the SAMHSA Acting 
Deputy Assistant Secretary for Mental Health and Substance Use in 
accordance with 5 U.S.C. 552b(c)(4) and (6) and 5 U.S.C. App. 2, 10(d).
    Meeting information and a roster of Council members may be obtained 
by accessing the SAMHSA Committee Web site at https://www.samhsa.gov/about-us/advisory-councils/csat-national-advisory-council or by 
contacting the CSAT National Advisory Council Designated Federal 
Officer, Tracy Goss (see contact information below).
    Council Name: SAMHSA's Center for Substance Abuse Treatment 
National Advisory Council.
    Date/Time/Type: April 12, 2017, 3:00 p.m.-4:00 p.m. EDT, CLOSED.
    Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857.
    Contact: Tracy Goss, Designated Federal Officer, CSAT National 
Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), 
Telephone: (240) 276-0759, Fax: (240) 276-2252, Email: 
tracy.goss@samhsa.hhs.gov.

Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017-06168 Filed 3-28-17; 8:45 am]
 BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.